Results 91 to 100 of about 24,117 (172)

Cancer Neuroscience: From Hallmark‐Enabling Biology to a Therapeutic Pillar

Advanced Oncology, Volume 1, Issue 1, December 2026.
Moran Amit
wiley   +1 more source

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands

, 2011
Bart Hoogveldt1, Benoît Rive2, Johan Severens3, Khaled Maman4, Chantal Guilhaume51Field Product Management, Lundbeck BV, Amsterdam, The Netherlands; 2Global Outcomes Research, Lundbeck SAS, Issy-les-Moulineaux, France; 3Institute of Health ...
Maman K, Rive B, Severens J, Guilhaume C, Hoogveldt B   +3 more
core  

Memantine (Ebixa) in clinical practice - results of an observational study.

, 2007
BACKGROUND/AIMS: In a post-marketing observational study, the efficacy and tolerability of memantine were examined in patients with moderate to severe Alzheimer's disease.
Calabrese, P;Essner, U;Förstl, H, Calabrese, Pasquale;Essner, Ute;Förstl, Hans   +1 more
core   +1 more source

Memantine Inhibits Calcium-Permeable Ampa Receptors

Memantine is an US Food and Drug Administration (FDA) approved drug that is thought to selectively inhibit NMDA-subtype of ionotropic glutamate receptors (NMDARs).
Gonzalez, Cuauhtemoc U, Turcu, Andreea L, Vázquez, Santiago, Carrillo, Elisa, Jayaraman, Vasanthi, Montaño Romero, Alejandra, Twomey, Edward C   +6 more
core   +1 more source

Evaluating High-Dose Rivastigmine Patch in Severe Alzheimer’s Disease: Analyses with Concomitant Memantine Usage as a Factor

, 2015
Background: ACTION, a 24-week, prospective, randomized, parallel-group, double-blind study in patients with severe Alzheimer’s disease (AD), demonstrated significant efficacy of 13.3 mg/24 h versus 4.6 mg/24 h rivastigmine patch on the Severe Impairment ...
Meng, Xiangyi, Grossberg, George T., Farlow, Martin R., Velting, Drew M.   +3 more
core   +1 more source

The Effects of Co-Administration of Memantine And Vitamin D on Spatial Learning and Memory Impairment in Adult Male Rats Model of Alzheimer’s Disease

Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Arāk, 2020
Background and Aim: Alzheimer’s disease is the most common causes of dementia among the elderly people. The aim of this study was to evaluate the synergistic effects of memantine and vitamin D on spatial learning and memory impairment in adult male rat ...
Nastaran Zamani, Ahmad Ali Moazedi
doaj  

The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome.

PLoS ONE, 2012
Although the pathogenic mechanisms that underlie autism are not well understood, there is evidence showing that metabotropic and ionotropic glutamate receptors are hyper-stimulated and the GABAergic system is hypo-stimulated in autism.
Hongen Wei, Carl Dobkin, Ashfaq M Sheikh, Mazhar Malik, W Ted Brown, Xiaohong Li   +5 more
doaj   +1 more source

Effect of memantine on neuropathic pain induced by mastectomy.

, 2016
Effect of memantine on neuropathic pain induced by mastectomy.
Xavier Durando (2600911), Christine Villatte (2600917), Laurence Daulhac (441656), Delphine Roux (2600902), Bruno Pereira (415597), Véronique Morel (2600908), Dominique Joly (12402), Gisèle Pickering (2600914), Claude Dubray (195841), Catherine Coudert (2600905)   +9 more
core   +1 more source

Chemical structures of Memantine, Amantadine and MK-801.

, 2014
Chemical structures of Memantine, Amantadine and MK-801.
Lisvane Silva Paes (267021), Ariel Mariano Silber (167356), María Julia Barisón (528521), Elisabeth Mieko Furusho Pral (435602), Flávia Silva Damasceno (528520)   +4 more
core   +1 more source

Memantine enhances the inhibitory effects of naltrexone on ethanol consumption

, 2008
Effects of the opioid receptor antagonist naltrexone (0.1; 0.3; 1.0 mg/kg i.p.) on operant ethanol self-administration alone and in combination with the non-competitive NMDA antagonist memantine (0.5 and 1 mg/kg, i.p.) were studied in rats.
Kuzmin, A, Stenback, T, Liljequist, S
core   +1 more source